In our work, we sought to assess if aberrant methylation at the gene promoter region should be considered as one mechanism of SPARC dysregulation in lung fibrosis and if SPARC methylation correlates with IPF and/or NIPF. The gene discussed is SPARC; the disease is pulmonary fibrosis.